Research Paper on Chimeric Autoantibody Receptor T Cells for ANCA Vasculitis

A 2.9 MB PDF research paper authored by Heather M. Sosnoski and last updated on May 8, 2026. The paper details the development of MPO chimeric autoantibody receptor (CAAR) T cells as a targeted therapy for ANCA vasculitis, an autoimmune disorder affecting the lungs and kidneys. It describes in vitro and in vivo experiments demonstrating the selective elimination of autoreactive B cells.

Use Cases

• Reviewing experimental methods for targeted B cell depletion based on the described in vitro and in vivo studies.
• Analyzing the therapeutic potential of chimeric autoantibody receptor T cells for autoimmune disorders based on the described findings.
• Studying the mechanisms of ANCA vasculitis and MPO-specific autoantibodies based on the background provided in the paper.

Strengths

• File size is explicitly stated as 2.9 MB, indicating a manageable download.
• License is clearly defined as CC-BY-4.0, permitting reuse with attribution.
• Author and last update timestamp (2026-05 08 05:51:07) are provided.

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Heather M. Sosnoski via figshare

Collection Method

Likely contains research findings from laboratory experiments.

Time Range

Paper last updated 2026-05-08; research timeframe is unspecified.

Freshness

Last updated 2026-05-08 05:51:07; freshness should be verified.

Geography

null